<p><i>Salmonella</i> Typhimurium is a significant pathogen causing diarrhea in weaned piglets, capable of triggering systemic inflammation and severe intestinal damage. As bioactive components of gut microbiota, extracellular vesicles (EVs) derived from <i>Lactobacillus johnsonii</i> (Lj-EVs) are likely to penetrate the intestinal mucus layer and reach host cells, potentially mediating host-microbiome interactions. Here, we found that Lj-EVs improved the intestinal barrier and attenuated intestinal injury in mice infected with <i>S.</i> Typhimurium. Multi-omics analysis showed that Lj-EVs intervention enriched mucin-utilizing <i>Akkermansia</i>. Moreover, Lj-EVs were associated with metabolic alterations, characterized by enhanced oxidative phosphorylation during homeostasis and suppression of HIF-1α-mediated glycolysis during infection. Proteomic profiling showed that Lj-EVs enriched functional proteins related to oxidative phosphorylation, indicating their potential immunomodulatory role. Notably, Lj-EVs modulated macrophage-mediated immune responses, contributing to limiting bacterial dissemination and alleviating intestinal inflammation. In conclusion, our study demonstrates that Lj-EVs alleviate <i>Salmonella</i> infection by reducing bacterial burden and confer metabolic and immunomodulatory benefits. These findings provide new evidence for future investigation of the protective roles of probiotic vesicles.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Lactobacillus johnsonii-derived extracellular vesicles modulate gut microbiota metabolites and macrophage-related immune responses against Salmonella Typhimurium infection

  • Yi Wu,
  • Keyuan Chen,
  • Ting Hu,
  • Yaoyao Luo,
  • Yue Zhang,
  • Guiyan Yang,
  • Jiufeng Wang,
  • Yaohong Zhu

摘要

Salmonella Typhimurium is a significant pathogen causing diarrhea in weaned piglets, capable of triggering systemic inflammation and severe intestinal damage. As bioactive components of gut microbiota, extracellular vesicles (EVs) derived from Lactobacillus johnsonii (Lj-EVs) are likely to penetrate the intestinal mucus layer and reach host cells, potentially mediating host-microbiome interactions. Here, we found that Lj-EVs improved the intestinal barrier and attenuated intestinal injury in mice infected with S. Typhimurium. Multi-omics analysis showed that Lj-EVs intervention enriched mucin-utilizing Akkermansia. Moreover, Lj-EVs were associated with metabolic alterations, characterized by enhanced oxidative phosphorylation during homeostasis and suppression of HIF-1α-mediated glycolysis during infection. Proteomic profiling showed that Lj-EVs enriched functional proteins related to oxidative phosphorylation, indicating their potential immunomodulatory role. Notably, Lj-EVs modulated macrophage-mediated immune responses, contributing to limiting bacterial dissemination and alleviating intestinal inflammation. In conclusion, our study demonstrates that Lj-EVs alleviate Salmonella infection by reducing bacterial burden and confer metabolic and immunomodulatory benefits. These findings provide new evidence for future investigation of the protective roles of probiotic vesicles.